Category Biology/Biotechnology

Gut Microbiome Influences Location of Immune Cells, study finds

Researchers at the Experimental and Clinical Research Center of Max Delbrück Center and Charité — Universitätsmedizin Berlin (ECRC) have found that different anatomical sections of the gastrointestinal tracts of mice carry different compositions of microbial communities. Moreover, the specific makeup of the microbiota can influence the type and abundance of immune cells in any particular region. The study, which was published in Gut Microbes, maps the complex spatial organization of immune cells and microbial communities, providing a tool for studying the interaction between gut microbes and inflammatory diseases.

Previous research has hinted at the existence of “hotspots” along the GI tract where specific immune cells and microbes might interact more intensely.

But no one ha...

Read More

Like Father, Like Daughter

Changcheng Zhou (right) is seen here with Rebecca Hernandez, the first author of the research paper. (Carrie Rosema)

Mouse study finds fathers on unhealthy diets can cause cardiovascular disease in their daughters. When they become fathers, men who have an unhealthy, high-cholesterol diet can cause increased risk of cardiovascular disease, or CVD, in their daughters, a University of California, Riverside-led mouse study has found.

The research, published in the journal JCI Insight, is the first to demonstrate this result seen only in female offspring.

CVD, the leading cause of death globally, is a group of disorders that affects the heart and blood vessels. Hypertension (high blood pressure) is a leading risk factor for CVD...

Read More

Scientists Discover Dual Roles of Antibodies in COVID-19 Infections

Midwest AViDD
Structure of SARS-CoV-2 Omicron spike complexed with Nanosota-5

Scientists at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center have made a surprising discovery: antibodies can have opposite effects on viral infections in human cells.

The spike protein of SARS-CoV-2, the virus that causes COVID-19, enables the virus to enter human cells and is the primary target for the body’s antibodies. Previous research has shown that antibodies can either block the virus, have no effect, or, in rare cases, assist the virus in infecting cells. While antibody drugs work to block infections, this new study challenges current understanding of their mechanisms.

Published in the journal PLOS Pathogens, this study is the first to identify an antibody that can both a...

Read More

Scientists Learn how to Drug Wily Class of Disease-Causing Enzymes

An illustration of a GTPase thethered to a cell.
A GTPase (center) tethered to the outside of a cell (bottom), with several drugs in the distance. Credit: Inmywork Studio

Drugs for the K-Ras oncogene inspire an approach for targeting the GTPases, a family of enzymes whose dysfunction can lead to Parkinson’s and many other diseases.

UCSF scientists have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases from Parkinson’s to cancer and have long been thought to be “undruggable.”

Because of their slippery exteriors, the GTPases have remained largely out of reach of modern drug discovery, with the exception of the notorious cancer-causing GTPase called K-Ras.

On a hunch, the team tested a dozen drugs that target K-Ras against a handful of GTPases they had mutated to mak...

Read More